Biomimetics of Limulus Immune System and Its Medical Applications

Abstract

Abstract: Biomemetics (or bionics) as a scientific discipline has potential applications in various research fields as well as in improving human lives. In the field of medicine and pharmacy, biomimetic methods are of great value in developing drugs, developing methods for the diagnosis, prevention and treatment of diseases.

Biomimetics of immune system in medicine and pharmacy is a great subject with the potential to make remarkable progress. The immune system of the species is rich, diverse and has different mechanisms. This study investigates the biomimetics of Limulus immune system and its practical application prospects.

Keywords: Biomimetics, Limulus, immunology, practical applications.

References:

[1] Hwang Jangsun, Jeong Yoon, Park Jeong Min, Lee Kwan Hong, Hong Jong Wook, Choi Jonghoon, Biomimetics: forecasting the future of science, engineering, and medicine, International Journal of Nanomedicine 10 (2015) 5701-5713.
[2] Nguyễn Thanh Hải, Bùi Thanh Tùng, Phạm Thị Minh Huệ, Phỏng sinh học trong y dược học – Hướng nghiên cứu cần được đẩy mạnh, Tạp chí Khoa học Đại học Quốc gia Hà Nội – Khoa học Y Dược 33(1) (2017) 1.
[3] Vikash Kumar, Suvra Roy, A.K. Sahoo, B.K. Behera, A.P. Sharma, Horseshoe crab and its medicinal values, International Journal of Current Microbiology and Applied Sciences 4 (2) (2015) 956-964.
[4] Elizabeth A. Walls, Jim Berkson, Stephen A. Smith, The Horseshoe Crab, Limulus polyphemus: 200 Million Years of Existence, 100 Years of Study, Reviews in Fisheries Science 10 (1) (2002) 39-73.
[5] Vikash Kumar, Suvra Roy, A.K. Sahoo, Vikas Kumar, Horseshoe crabs: biomedical importance and its potential use in developing health-care products, Indian Journal of Geo-Marine Sciences 45 (10) (2016) 1234-1244.
[6] Iwanaga S., Lee B.L., Recent Advances in the Innate Immunity of Invertebrate Animals, Journal of Biochemistry and Molecular Biology 38 (2) (2005) 128-150.
[7] Iwanaga S., Kawabata S., Evolution and phylogeny of defense molecules associated with innate immunity in horseshoe crab, Frontiers in Bioscience 3 (1998) 973-984.
[8] Iwanaga S., The molecular basis of innate immunity in the horseshoe crab, Current Opinion in Immunology 14 (2002) 87-95.
[9] Iwanaga S., Muta T., Shigenaga T., Miura Y., Seki N., Saito T., Kawabata S., Role of hemocyte-derived granular components in invertebrate defense,Annals of the New York Academy of Sciences 712 (1994) 102-116.
[10] Bang F.B., A bacterial disease of Limulus Polyphemus, Bulletin of the Johns Hopkins Hospital 98 (1956) 325-351.
[11] Tamura H., Tanaka S., Oda T., Uemura Y., Aketagawa J., Hashimoto Y., Purification and characterization of a (13)-β-D-glucan binding protein from horseshoe crab (Tachypleus tridentatus) amoebocytes, Carbohydrate Research 295 (1996) 103-116.
[12] Osaki T., Okino N., Tokunaga F., Iwanaga S., Kawabata S., Proline-rich cell surface antigens of horseshoe crab hemocyté are substrates for protein cross-linking with clotting protein coagulin, Journal of Biological Chemistry277 (2002) 40084-40090.
[13] Krem M.M., Cera E.D., Evolution of enzyme cascades from embryonic development to blood coagulation, Trends in Biochemical Sciences 27 (2002) 67-74.
[14] Dawson ME, Novitsky TJ, Gould MJ, Microbes, endotoxins and water, Pharmaceutical Engineering 8(2) (1988) 9–12.
[15] Thomas J. Novitsky, Biomedical Applications of Limulus Amebocyte Lysate, Biology and Conservation of Horseshoe Crabs (2009) 315-329.
[16] Armstrong PB, Internal defense against pathogenic invasion: The immune system, The American Horseshoe Crab, Harvard University Press, Cambridge (2003) 288–309.
[17] Morita T, Tanaka S, Nakamura T, Iwanaga S, A new (1–3)-ß-D-glucan-mediated coagulation pathway found in Limulus amebocytes, FEBS Letters 129 (1981) 318–321.
[18] Novitsky TJ, Industrial application of the LAL test, Rapid detection of bacteria and bacterial endotoxins (1988) 179–180.
[19] Novitsky TJ, Monitoring and validation of high purity water systems with the Limulus amebocyte lysate test for pyrogens, Pharmaceutical Engineering 4 (1984) 21–33.
[20] Case MJ, Ryther SS, Novitsky TJ, Detection of endotoxin in antibiotic solutions with Limulus amoebocyte lysate, Antimicrobial Agents and Chemotherapy 23 (1983) 649–652.
[21] Arduino MJ. Bland LA, Tipple MA, Aguero SM, Favero MS, Jarvis WR, Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes, Journal of Clinical Microbiology 27 (1989) 1483–1485.
[22] Romero R, Roslansky PF, Oyarzun E, Wan M, Emamian M, Novitsky TJ, Gould MJ, Hobbins JC, Labor and infection Bacterial endotoxin in amniotic fluid and its relationship to the onset of preterm labor, American Journal of Obstetrics and Gynecology 158 (1988) 1044–1049.
[23] Warren HS, Novitsky TJ, Ketchum PA, Roslansky PF, Kania S, Siber GR, Neutralization of bacterial lipopolysaccharides by human plasma, Journal of Clinical Microbiology 22 (1985) 590–595.
[24] Riveau, GR, Novitsky TJ, Roslansky PF, Warren HS, Dinarello CA, Role of interleukin-1 in augmenting serum neutralization of bacterial lipopolysaccharide, Journal of Clinical Microbiology25 (1987) 889–892.
[25] Warren HS, Novitsky TJ, Martin P, Roslansky PF, Siber GR, Endotoxin neutralizing capacity of sera from different patient populations assessed by the Limulus lysate test, Detection of bacterial endotoxins with the Limulus amebocyte lysate test (1987) 341–348.
[26] Stack AM, Saladino RA, Siber GR, Thompson C, Marra MN, Novitsky TJ, Fleisher GR, A comparison of bactericidal/permeability versus increasing protein variant recombinant endotoxin-neutralizing protein for the treatment of Escherichia coli sepsis in rats, Critical Care Medicine 25 (1997) 101–105.
[27] Andra¨ J, Garidel P, Majerle A, Jerala R, Ridge R, Paus E, Novitsky T, Koch MHJ, Brandendurg K, Biophysical characterization of the interaction of Limulus polyphemus endotoxin neutralizing protein with lipopolysaccharide, European Journal of Biochemistry 271 (2004) 2037–2046.
[28] Obayashi T, Yashida M, Mori T, Goto H, Yasuoka A, Iwansaki H, Teshima H, Kohno S, Horiuchi A, Ito A, Yamanguchi H, Shimada K, Kawai T, Plasma (1–3)-ß-D-glucan measurement in diagnosis of deep mycosis and fungal febrile episodes, Lancet 345 (1995) 17–20.